Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
Public ClinicalTrials.gov record NCT02024646. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to evaluate the efficacy of brodalumab, compared to placebo, in subjects with psoriatic arthritis. The key secondary objective is to evaluate the efficacy of brodalumab compared to placebo at week 16. The safety objective of this study is to evaluate the safety profile of brodalumab in subjects with psoriatic arthritis.
Study identification
- NCT ID
- NCT02024646
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 484 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2014
- Primary completion
- Sep 30, 2015
- Completion
- Sep 30, 2015
- Last update posted
- Aug 19, 2020
2014 – 2015
United States locations
- U.S. sites
- 31
- U.S. states
- 17
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Peoria | Arizona | 85381 | — |
| Research Site | Little Rock | Arkansas | 72205 | — |
| Research Site | Cypress | California | 90630 | — |
| Research Site | Hemet | California | 92543 | — |
| Research Site | Huntington Beach | California | 92646 | — |
| Research Site | La Jolla | California | 92037 | — |
| Research Site | Palm Desert | California | 92260 | — |
| Research Site | Palo Alto | California | 94304 | — |
| Research Site | Victorville | California | 92395 | — |
| Research Site | Sarasota | Florida | 34239 | — |
| Research Site | St. Petersburg | Florida | 33705 | — |
| Research Site | Tampa | Florida | 33612 | — |
| Research Site | Tampa | Florida | 33614 | — |
| Research Site | Chicago | Illinois | 60611 | — |
| Research Site | Paducah | Kentucky | 42003 | — |
| Research Site | Baton Rouge | Louisiana | 70809 | — |
| Research Site | Wheaton | Maryland | 20902 | — |
| Research Site | Boston | Massachusetts | 02111 | — |
| Research Site | Battle Creek | Michigan | 49017 | — |
| Research Site | Grand Rapids | Michigan | 49546 | — |
| Research Site | Lansing | Michigan | 48910 | — |
| Research Site | St Louis | Missouri | 63141 | — |
| Research Site | Las Vegas | Nevada | 89102 | — |
| Research Site | Rochester | New York | 14642 | — |
| Research Site | Oklahoma City | Oklahoma | 73103 | — |
| Research Site | Tulsa | Oklahoma | 74104 | — |
| Research Site | Dallas | Texas | 75231 | — |
| Research Site | Dallas | Texas | 75246 | — |
| Research Site | Waco | Texas | 76708 | — |
| Research Site | Chesapeake | Virginia | 23320 | — |
| Research Site | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 72 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02024646, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 19, 2020 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02024646 live on ClinicalTrials.gov.